NATCO PHARMA
Back to Cashflow Statement
|
NATCO PHARMA Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹1,768 Cr | ₹1,697 Cr | ₹1,212 Cr | ₹849 Cr | ₹47 Cr |
What is the latest Cash Flow from Operating Activities ratio of NATCO PHARMA ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2026 | ₹1,768 Cr |
| Mar2025 | ₹1,697 Cr |
| Mar2024 | ₹1,212 Cr |
| Mar2023 | ₹849 Cr |
| Mar2022 | ₹47 Cr |
How is Cash Flow from Operating Activities of NATCO PHARMA Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹1,768 Cr | 4.21 | |
| Mar2025 | ₹1,697 Cr | 40.05 | |
| Mar2024 | ₹1,212 Cr | 42.69 | |
| Mar2023 | ₹849 Cr | 1,726.02 | |
| Mar2022 | ₹47 Cr | - | |
Compare Cash Flow from Operating Activities of peers of NATCO PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NATCO PHARMA | ₹15,399.7 Cr | 0.2% | -2.8% | -0.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹418,684.0 Cr | -0.2% | -4.9% | 5.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹242,904.0 Cr | 1.3% | -2.3% | 38.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹172,213.0 Cr | -1.5% | -5.8% | 29.3% | Stock Analytics | |
| CIPLA | ₹106,138.0 Cr | 0.1% | -4.2% | -14.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,304.0 Cr | 1.9% | 5.7% | 0.4% | Stock Analytics | |
NATCO PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NATCO PHARMA | 0.2% |
-2.8% |
-0.3% |
| SENSEX | 0.9% |
-0.8% |
-10.5% |
You may also like the below Video Courses